Institutional Biosafety Committee

Overview

The Institutional Biosafety Committee (IBC) is a University-wide group Committee responsible for reviewing and approving recombinant or synthetic nucleic acid molecules research and biohazard research projects. The IBC has overall oversight responsibility for the Biosafety Program at Boston University and Boston Medical Center. The IBC carries out these functions pursuant to requirements set forth by federal, state, and local agencies as well as Boston University.

Activities and Performances of the IBC office are available in our Annual Report section.

How to:

Check for Regulatory Updates and IBC News:

IBC Public Meeting

Pursuant to Section 2.03 of the Boston Public Health Commission’s Biological Laboratory Regulation, the Institutional Biosafety Committee (IBC) of Boston University will hold its annual public meeting on September 20, 2016 from 12:00 PM -3:00 PM at the Boston University School of Medicine, 72 East Concord Street, in L109 Conference Room,1st Floor, Boston, Massachusetts.